Home > Insider Trading > Filing (0001181431-13-038919)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1509190	Aratana Therapeutics Inc.	PETX	Pharmaceutical Preparations (2834)	383826477

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1352447	Steven Peter St	C/O Aratana Therapeutics, Inc. 1901 Olathe Boulevard Kansas City KS 66103	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-02	11,281	$0.00	86,997	No	4	C	Indirect	BY LLC
Common Stock	Acquisiton	2013-07-02	8,333	$6.00	529,191	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	BY LLC
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	SERIES C CONVERTIBLE PREFERRED STOCK	Disposition	2013-07-02	18,750	$0.00	11,281	$6.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Series C Convertible Preferred Stock (the "Preferred Stock") has no expiration date. The shares of Preferred Stock reported on this line item converted into shares of the Issuer's Common Stock on a 1-for-0.601685 basis upon the closing of the Issuer's initial public offering (the "IPO Closing").
The reporting person acquired an aggregate of 506 shares of common stock as a stock dividend on the IPO Closing which are reflected in the aggregate holdings set forth in Column 5.
Held in the name of Vie Venture LLC, a Delaware limited liability company ("Vie Venture"). The Reporting Person has sole voting and dispositive power over the shares held by Vie Venture, but disclaims beneficial ownership of the shares held thereby except to the extent of his pecuniary interest therein.